Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Chemotherapy can harm kidneys in breast cancer patients.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

More effective methods are needed to prevent hair loss from chemotherapy.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

PPX causes much less hair loss than traditional taxanes.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Chemotherapy caused the patient's hair to have alternating thick and thin segments.

Chemotherapy reduces splenic melanin in mice.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Promising cancer treatments were found, but the manufacturer closed.